| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-05 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0002 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.27 | 0.0002 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.28 | 0.0002 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0003 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.26 | 0.0004 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0004 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.18 | 0.0005 |